References
- TohenMFrankEBowdenCLThe International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersBipolar Disord20091145347319624385
- OrrKTaylorDPsychostimulants in the treatment of depression: a review of the evidenceCNS Drugs20072123925717338594
- CandyMJonesLWilliamsRTookmanAKingMPsychostimulants for depressionCochrane Database Syst Rev20082CD00672218425966
- StollALPillaySSDiamondLWorkumSBColeJOMethylphenidate augmentation of serotonin selective reuptake inhibitors: a case seriesJ Clin Psychiatry19965772768591972
- MetzAShaderRICombination of fluoxetine with pemoline in the treatment of major depressive disorderInt Clin Psychopharmacol1991693961960383
- StahlSMEssential Psychopharmacology of Depression and Bipolar DisorderCambridge, UKCambridge University Press2000
- NierenbergAADoughertyDRosenbaumJFDopaminergic agents and stimulants as antidepressant augmentation strategiesJ Clin Psychiatry199859Suppl 560639635549
- ThaseMEFavaMDeBattistaCAroraSHughesRJModafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension studyCNS Spectr2006119310216520686
- American Psychiatric Association, DSM-5 Task ForceDiagnostic and Statistical Manual of Mental Disorders: DSM-5Arlington, VA, USAAmerican Psychiatric Association2013
- HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
- GuyWClinical global impressions ECDEU Assessment Manual for PsychopharmacologyRockville, MD, USADepartment of Health, Education, and Welfare1976
- StahlSMStahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Application3rd edNew York, NY, USACambridge University Press2008
- PatkarAAMasandPSPaeC-UA randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depressionJ Clin Psychopharmacol20062665365617110825